BMY Bristol Myers Squibb Company: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Lambang korporat lan logo bms.com (BMY)

The time-series assessment of future earnings per share on the GURU.Markets chart demonstrates trends where 3.80 expresses the latest metric level. Bristol-Myers Squibb (BMY) is implementing "green chemistry" and ESG standards into its production. A stable roster of top oncology researchers supports the brand, although the risk of losing patent exclusivity is currently exerting pressure on the company's investment attractiveness.

BMY: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Bristol Myers Squibb Company 04.07.2022 - 18.11.2026

Bristol Myers Squibb - rincian analitis lan metrik utama (BMY)

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:BMY, bms.com
Barang utama bms.com

A conservative approach to analyzing Bristol-Myers Squibb (BMY) requires evaluating future cash flows through the lens of market expectations. This metric aggregates expert earnings per share (EPS) forecasts, reflecting the speed of business valuation adjustments during external shocks. The trend in the consensus EPS forecast demonstrates the resilience of sales margins for patented drugs in oncology and cardiology. The growth of this indicator confirms the investment attractiveness of Bristol-Myers Squibb (BMY) as a stable asset.